These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11216897)

  • 1. Mutation screening for prenatal and presymptomatic diagnosis: cystic fibrosis and haemochromatosis.
    Stuhrmann M; Graf N; Dörk T; Schmidtke J
    Eur J Pediatr; 2000 Dec; 159 Suppl 3():S186-91. PubMed ID: 11216897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reverse cascade screening of newborns for hereditary haemochromatosis: a model for other late onset diseases?
    Cadet E; Capron D; Gallet M; Omanga-Léké ML; Boutignon H; Julier C; Robson KJ; Rochette J
    J Med Genet; 2005 May; 42(5):390-5. PubMed ID: 15863667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of the Cys282Tyr HFE mutation facilitates an improved diagnostic service for hereditary haemochromatosis in South Africa.
    de Villiers JN; Hillerman R; de Jong G; Langenhoven E; Rossouw H; Marx MP; Kotze MJ
    S Afr Med J; 1999 Mar; 89(3):279-82. PubMed ID: 10226674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal Diagnosis of Cystic Fibrosis.
    Fedick AM; Zhang J; Edelmann L; Kornreich R
    Methods Mol Biol; 2019; 1885():221-231. PubMed ID: 30506201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections.
    Comeau AM; Parad RB; Dorkin HL; Dovey M; Gerstle R; Haver K; Lapey A; O'Sullivan BP; Waltz DA; Zwerdling RG; Eaton RB
    Pediatrics; 2004 Jun; 113(6):1573-81. PubMed ID: 15173476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA testing for haemochromatosis: diagnostic, predictive and screening implications.
    Trent RJ; Le H; Yu B; Young G; Bowden DK
    Pathology; 2000 Nov; 32(4):274-9. PubMed ID: 11186424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CFTR DeltaF508 mutation detection from dried blood samples in the first trimester of pregnancy: a possible routine prenatal screening strategy for cystic fibrosis?
    Konialis CP; Hagnefelt B; Kazamia C; Karapanou S; Pangalos C
    Fetal Diagn Ther; 2007; 22(1):41-4. PubMed ID: 17003555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Best practice guidelines for the molecular genetic diagnosis of Type 1 (HFE-related) hereditary haemochromatosis.
    King C; Barton DE
    BMC Med Genet; 2006 Nov; 7():81. PubMed ID: 17134494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Frequency of HFE gene mutations and genotype-phenotype correlations in patients with hereditary hemochromatosis in Switzerland].
    Himmelmann A; Bortoluzzi L; Jansen S; Fehr J
    Schweiz Med Wochenschr; 2000 Aug; 130(31-32):1112-9. PubMed ID: 11008304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic analysis of cystic fibrosis in Denmark. Implications for genetic counselling, carrier diagnosis and prenatal diagnosis.
    Schwartz M; Brandt NJ; Koch C; Lanng S; Schiøtz PO
    Acta Paediatr; 1992; 81(6-7):522-6. PubMed ID: 1392366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [DNA analysis and gene diagnosis of cystic fibrosis].
    Kobayashi K
    Rinsho Byori; 1991 Oct; 39(10):1057-64. PubMed ID: 1722259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular genetic diagnostics and screening of hereditary hemochromatosis].
    Zlocha J; Kovács L; Pozgayová S; Kupcová V; Durínová S
    Vnitr Lek; 2006 Jun; 52(6):602-8. PubMed ID: 16871764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Searching for hereditary hemochromatosis.
    Laudicina RJ
    Clin Lab Sci; 2006; 19(3):174-83. PubMed ID: 16910235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is cystic fibrosis carrier screening cost effective?
    Wei S; Quigg MH; Monaghan KG
    Community Genet; 2007; 10(2):103-9. PubMed ID: 17380060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New strategy for the prenatal detection/exclusion of paternal cystic fibrosis mutations in maternal plasma.
    Bustamante-Aragones A; Gallego-Merlo J; Trujillo-Tiebas MJ; de Alba MR; Gonzalez-Gonzalez C; Glover G; Diego-Alvarez D; Ayuso C; Ramos C
    J Cyst Fibros; 2008 Nov; 7(6):505-10. PubMed ID: 18573697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An update on cystic fibrosis screening.
    Goetzinger KR; Cahill AG
    Clin Lab Med; 2010 Sep; 30(3):533-43. PubMed ID: 20638569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Underdiagnosis of hereditary haemochromatosis: lack of presentation or penetration?
    Ryan E; Byrnes V; Coughlan B; Flanagan AM; Barrett S; O'Keane JC; Crowe J
    Gut; 2002 Jul; 51(1):108-12. PubMed ID: 12077102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of genetic testing and family health history of cystic fibrosis in the early prenatal diagnosis and prevention of a new case of genetic disorder.
    Albu CC; Stancu IG; Grigore LG; Albu DF; Albu ŞD; Pătraşcu A; Gogănău AM
    Rom J Morphol Embryol; 2019; 60(2):667-671. PubMed ID: 31658342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for carriers of cystic fibrosis among pregnant women: a pilot study.
    Schwartz M; Brandt NJ; Skovby F
    Eur J Hum Genet; 1993; 1(3):239-44. PubMed ID: 8044649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cystic Fibrosis: A Review of Associated Phenotypes, Use of Molecular Diagnostic Approaches, Genetic Characteristics, Progress, and Dilemmas.
    Brennan ML; Schrijver I
    J Mol Diagn; 2016 Jan; 18(1):3-14. PubMed ID: 26631874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.